Fall / 2007

Beneficial Risk

BY JO CAVALLO

Questions about the safety of approved drugs has the FDA poised to reform. But with cancer patients willing to accept a higher level of risk, what will changes mean for them?

ARTICLE EXTRAS The FDA Speaks Out on Drug Safety What to Do If You Experience an ADR Web Exclusive: Drug Safety in Europe

The HRT Connection

BY ELIZABETH WHITTINGTON

Are breast cancer rates dropping because of the HRT decline, or are other factors at work?

ARTICLE EXTRAS
Breaking Down the Risks & Benefits of HRT
Hot Flashes: What Are the Alternatives?
Web Exclusive: Ongoing HRT Research

The New Sarcoma Story

BY BEVERLY A. CALEY

Strategies for diagnosing and treating sarcomas shift to a more patient-specific approach.

ARTICLE EXTRAS
Dealing With Disfigurement
Secondary Sarcomas
Web Exclusive: Types of Sarcoma

Contents

First Line

People, News & Events

EDITED BY ELIZABETH WHITTINGTON

Legislative Watch / People Report / The Place to Be / Prevention / House Call / Childhood Cancer / Destination / On the Web / Bookshelf / The Advocate

Diagnosis Cancer

Powers of Prediction

BY AMY K. ERICKSON

Predictive markers help oncologists match patients with the most effective treatments. 

Finding Hope

Use As Directed

BY LAURA BEIL

As more cancer drugs become self-administered, why aren’t patients taking their medicine?  

Moving On

All in the Family

BY CHARLOTTE HUFF

Registries reveal links for cancer that runs in the family. 

Caregivers' Corner

Grief Before Death

BY MARC SILVER

Struggling with the sorrow of anticipatory grief.